LYCOS RETRIEVER 
Cystic Fibrosis
built 126 days ago
Cystic Fibrosis is a genetic disease that affects approximately 30,000 people in the United States. CF is the most common life-threatening autosomal recessive disorder in the Caucasian population. CF occurs in approximately one of every 3,200 live Caucasian births (in one of every 3,900 live births of all Americans). About 1,000 new cases of CF are diagnosed each year. A defective gene causes the body to produce abnormally thick, sticky mucus that leads to chronic and life-threatening lung infections and impairs digestion. The median age of survival for people with CF is 33 years.
Source:
Cystic Fibrosis is a disease which affects the body's exocrine glands, including the pancreas, sweat glands, and the lungs. It is a hereditary disease most common in white children, occuring in about one in every 2000 births. It is less common among African-American children. (about one in 17,000 births), and even more rare among Orientals (one in 100,000 births ) The mode of inheritance is autosomal which means that it does not involve the x or y chromosomes, which determine sex. It is ... recessive, which means that the disease is inherited from both parents. About five percent caucasian Americans are believed to carry the gene.
Source:
Cystic Fibrosis - Cystic Fibrosis is a chronic, progressive, and often fatal genetic disease of the body's mucus glands. Symptoms sometimes include abnormal heart rhythms, malnutrition, poor growth, frequent respiratory infections, and breathing difficulties. Cystic Fibrosis can ... cause other medical problems including sinusitis, nasal polyps, hemoptysis (coughing of blood), abdominal pain and discomfort, gassiness, and rectal prolapse. It primarily affects the respiratory and digestive systems in children and young adults. The symptoms of Cystic Fibrosis are often apparent at birth or shortly thereafter; rarely do the signs wait until adolescence to show up. It is most commonly found in Caucasians, and the prognosis is moderate, with many patients living up to 30 years after diagnosis.
Source:
About SourceCF Clinical Research and Development: The new = company was=20 formed to serve the Cystic Fibrosis community through the = development of=20 new treatment options aimed at improving the lives of people = living with=20 this disease. "We are excited to serve the Cystic Fibrosis = Community in=20 this way" said Michael Walters, President and CEO of SourceCF. = "Life=20 expectancy continues to increase through new options and = approaches to=20 care delivery and large-scale clinical trials are needed to = support this=20 important work," Walters added. For more information, visit http://www.sourcecf.com/
Source:
MORE ABOUT
Cystic Fibrosis